Diverse biological responses to different cardiotonic steroids

Pathophysiology

Volumn 14, Issue 3-4, 2007, Pages 159-166

  Dvela, Moran ^a   Rosen, Haim ^a   Feldmann, Tomer ^a   Nesher, Maoz ^a   Lichtstein, David ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Bufalin; Cardenolides; Cardiac contractility; Digoxin; Endocytosis; Endogenous cardiotonic steroids; Na, K ATPase; Ouabain

Indexed keywords

EID: 36448949741     PISSN: 09284680     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pathophys.2007.09.011     Document Type: Article

References (80)

1. Guntert T.W., and Linde H.H.A. Chemistry and Structure-Activity Relationships of Cardioactive Steroids (1981), Springer Verlag, Berlin
2. Kelly R.A., and Smith T.W. Pharmacological Treatment of Heart Failure. ninth ed. (1996), McGraw-Hill Comp
3. Meyer K., and Linde H. Collection of Toad Venoms and Chemistry of the Toad Venom Steroids (1971), Academic Press, New York
4. Hamlyn J.M., Blaustein M.P., Bova S., DuCharme D.W., Harris D.W., Mandel F., Mathews W.R., and Ludens J.H. Identification and characterization of a ouabain-like compound from human plasma. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 6259-6263
5. Mathews W.R., DuCharme D.W., Hamlyn J.M., Harris D.W., Mandel F., Clark M.A., and Ludens J.H. Mass spectral characterization of an endogenous digitalis-like factor from human plasma. Hypertension 17 (1991) 930-935
6. Schneider R., Antolovic R., Kost H., Sich B., Kirch U., Tepel M., Zidek W., Schoner W., and Proscillaridin A. Immunoreactivity: its purification, transport in blood by a specific binding protein and its correlation with blood pressure. Clin. Exp. Hypertens. 20 (1998) 593-599
7. Kawamura A., Guo J., Itagaki Y., Bell C., Wang Y., Haupert Jr. G.T., Magil S., Gallagher R.T., Berova N., and Nakanishi K. On the structure of endogenous ouabain. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 6654-6659
8. Goto A., Yamada K., Ishii M., and Sugimoto T. Digitalis-like activity in human plasma: relation to blood pressure and sodium balance. Am. J. Med. 89 (1990) 420-426
9. Qazzaz H.M., Cao Z., Bolanowski D.D., Clark B.J., and Valdes Jr. R. De novo biosynthesis and radiolabeling of mammalian digitalis-like factors. Clin. Chem. 50 (2004) 612-620
10. Lichtstein D., Gati I., Samuelov S., Berson D., Rozenman Y., Landau L., and Deutsch J. Identification of digitalis-like compounds in human cataractous lenses. Eur. J. Biochem. 216 (1993) 261-268
11. Hilton P.J., White R.W., Lord G.A., Garner G.V., Gordon D.B., Hilton M.J., Forni L.G., McKinnon W., Ismail F.M., Keenan M., Jones K., and Morden W.E. An inhibitor of the sodium pump obtained from human placenta. Lancet 348 (1996) 303-305
12. Bagrov A.Y., Fedorova O.V., Dmitrieva R.I., Howald W.N., Hunter A.P., Kuznetsova E.A., and Shpen V.M. Characterization of a urinary bufodienolide Na+, K+-ATPase inhibitor in patients after acute myocardial infarction. Hypertension 31 (1998) 1097-1103
13. Komiyama Y., Dong X.H., Nishimura N., Masaki H., Yoshika M., Masuda M., and Takahashi H. A novel endogenous digitalis, telocinobufagin, exhibits elevated plasma levels in patients with terminal renal failure. Clin. Biochem. 38 (2005) 36-45
14. Nesher M., Shpolansky U., Rosen H., and Lichtstein D. The digitalis-like steroid hormones: new mechanisms of action and biological significance. Life Sci. 80 (2007) 2093-2107
15. Lee C.O. 200 years of digitalis: the emerging central role of the sodium ion in the control of cardiac force. Am. J. Physiol. 249 (1985) C367-C378
16. Levi A.J., Boyett M.R., and Lee C.O. The cellular actions of digitalis glycosides on the heart. Prog. Biophys. Mol. Biol. 62 (1994) 1-54
17. Smith T.W. The fundamental mechanism of inotropic action of digitalis. Therapie 44 (1989) 431-435
18. Wasserstrom J.A., and Aistrup G.L. Digitalis: new actions for an old drug. Am. J. Physiol. 289 (2005) H1781-H1793
19. Aydemir-Koksoy A., Abramowitz J., and Allen J.C. Ouabain-induced signaling and vascular smooth muscle cell proliferation. J. Biol. Chem. 276 (2001) 46605-46611
20. Haas M., Askari A., and Xie Z. Involvement of Src and epidermal growth factor receptor in the signal-transducing function of Na+/K+-ATPase. J. Biol. Chem. 275 (2000) 27832-27837
21. Haas M., Wang H., Tian J., and Xie Z. Src-mediated inter-receptor cross-talk between the Na+/K+-ATPase and the epidermal growth factor receptor relays the signal from ouabain to mitogen-activated protein kinases. J. Biol. Chem. 277 (2002) 18694-18702
22. Xie Z., and Xie J. The Na/K-ATPase-mediated signal transduction as a target for new drug development. Frontiers Biosci. 10 (2005) 3100-3109
23. Xie Z., and Cai T. Na+-K+-ATPase-mediated signal transduction: from protein interaction to cellular function. Mol. Interv. 3 (2003) 157-168
24. Aizman O., Uhlen P., Lal M., Brismar H., and Aperia A. Ouabain, a steroid hormone that signals with slow calcium oscillations. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 13420-13424
25. Miyakawa-Naito A., Uhlen P., Lal M., Aizman O., Mikoshiba K., Brismar H., Zelenin S., and Aperia A. Cell signaling microdomain with Na, K-ATPase and inositol 1,4,5-trisphosphate receptor generates calcium oscillations. J. Biol. Chem. 278 (2003) 50355-50361
26. Zhang S., Malmersjo S., Li J., Ando H., Aizman O., Uhlen P., Mikoshiba K., and Aperia A. Distinct role of the N-terminal tail of the Na, K-ATPase catalytic subunit as a signal transducer. J. Biol. Chem. 281 (2006) 21954-21962
27. Saunders R., and Scheiner-Bobis G. Ouabain stimulates endothelin release and expression in human endothelial cells without inhibiting the sodium pump. Eur. J. Biochem. 271 (2004) 1054-1062
28. Rosen H., Glukhman V., Feldmann T., Fridman E., and Lichtstein D. Cardiac steroids induce changes in recycling of the plasma membrane in human NT2 cells. Mol. Biol. Cell 15 (2004) 1044-1054
29. Blanco G., and Mercer R.W. Isozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function. Am. J. Physiol. 275 (1998) F633-F650
30. Paula S., Tabet M.R., and Ball Jr. W.J. Interactions between cardiac glycosides and sodium/potassium-ATPase: three-dimensional structure-activity relationship models for ligand binding to the E2-Pi form of the enzyme versus activity inhibition. Biochemistry 44 (2005) 498-510
31. Akimova O.A., Bagrov A.Y., Lopina O.D., Kamernitsky A.V., Tremblay J., Hamet P., and Orlov S.N. Cardiotonic steroids differentially affect intracellular Na+ and [Na+]i/[K+]i-independent signaling in C7-MDCK cells. J. Biol. Chem. 280 (2005) 832-839
32. Blanco G., Berberian G., and Beauge L. Detection of a highly ouabain sensitive isoform of rat brainstem Na, K-ATPase. Biochim. Biophys. Acta 1027 (1990) 1-7
33. O'Brien W.J., Lingrel J.B., and Wallick E.T. Ouabain binding kinetics of the rat alpha two and alpha three isoforms of the sodium-potassium adenosine triphosphate. Arch. Biochem. Biophys. 310 (1994) 32-39
34. Fedorova O.V., and Bagrov A.Y. Inhibition of Na/K ATPase from rat aorta by two Na/K pump inhibitors, ouabain and marinobufagenin: evidence of interaction with different alpha-subunit isoforms. Am. J. Hypertens. 10 (1997) 929-935
35. Oberfrank F., Vizi E.S., Baker P.F., Samuelov S., and Lichtstein D. Comparison of the effects of a bufodienolide and ouabain on neuronal and smooth muscle preparations. Neurosci. Res. 10 (1991) 235-244
36. Gao J., Wymore R.S., Wang Y., Gaudette G.R., Krukenkamp I.B., Cohen I.S., and Mathias R.T. Isoform-specific stimulation of cardiac Na/K pumps by nanomolar concentrations of glycosides. J. Gen. Physiol. 119 (2002) 297-312
37. Balzan S., D'Urso G., Ghione S., Martinelli A., and Montali U. Selective inhibition of human erythrocyte Na+/K+ ATPase by cardiac glycosides and by a mammalian digitalis like factor. Life Sci. 67 (2000) 1921-1928
38. de Lannoy I.A., and Silverman M. The MDR1 gene product, P-glycoprotein, mediates the transport of the cardiac glycoside, digoxin. Biochem. Biophys. Res. Commun. 189 (1992) 551-557
39. Efferth T., Davey M., Olbrich A., Rucker G., Gebhart E., and Davey R. Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells. Blood Cells Mol. Dis. 28 (2002) 160-168
40. Pauli-Magnus C., Murdter T., Godel A., Mettang T., Eichelbaum M., Klotz U., and Fromm M.F. P-glycoprotein-mediated transport of digitoxin, alpha-methyldigoxin and beta-acetyldigoxin. Naunyn Schmiedebergs Arch. Pharmacol. 363 (2001) 337-343
41. Wang H., Yuan W., and Lu Z. Effects of ouabain and digoxin on gene expression of sodium pump alpha-subunit isoforms in rat myocardium. Chin. Med. J. 114 (2001) 1055-1059
42. McGowan M.H., Russell P., Carper D.A., and Lichtstein D. Na+, K+-ATPase inhibitors down-regulate gene expression of the intracellular signaling protein 14-3-3 in rat lens. J. Pharmacol. Exp. Ther. 289 (1999) 1559-1563
43. Nakano H., Matsunawa M., Yasui A., Adachi R., Kawana K., Shimomura I., and Makishima M. Enhancement of ligand-dependent vitamin D receptor transactivation by the cardiotonic steroid bufalin. Biochem. Pharmacol. 70 (2005) 1479-1486
44. Akiyama M., Ogura M., Iwai M., Iijima M., Numazawa S., and Yoshida T. Effect of bufalin on growth and differentiation of human skin carcinoma cells in vitro. Hum. Cell 12 (1999) 205-209
45. 2+ increases and apoptosis in androgen-independent, metastatic human prostate adenocarcinoma cells. Cancer Res. 60 (2000) 3807-3812
46. Xiao A.Y., Wei L., Xia S., Rothman S., and Yu S.P. Ionic mechanism of ouabain-induced concurrent apoptosis and necrosis in individual cultured cortical neurons. J. Neurosci. 22 (2002) 1350-1362
47. Masuda Y., Kawazoe N., Nakajo S., Yoshida T., Kuroiwa Y., and Nakaya K. Bufalin induces apoptosis and influences the expression of apoptosis-related genes in human leukemia cells. Leukemia Res. 19 (1995) 549-556
48. Jing Y., Ohizumi H., Kawazoe N., Hashimoto S., Masuda Y., Nakajo S., Yoshida T., Kuroiwa Y., and Nakaya K. Selective inhibitory effect of bufalin on growth of human tumor cells in vitro: association with the induction of apoptosis in leukemia HL-60 cells. Jpn. J. Cancer Res. 85 (1994) 645-651
49. Zhang L., Nakaya K., Yoshida T., and Kuroiwa Y. Induction by bufalin of differentiation of human leukemia cells HL60, U937, and ML1 toward macrophage/monocyte-like cells and its potent synergistic effect on the differentiation of human leukemia cells in combination with other inducers. Cancer Res. 52 (1992) 4634-4641
50. Zhang L.S., Nakaya K., Yoshida T., and Kuroiwa Y. Bufalin as a potent inducer of differentiation of human myeloid leukemia cells. Biochem. Biophys. Res. Commun. 178 (1991) 686-693
51. Cavet M.E., West M., and Simmons N.L. Transport and epithelial secretion of the cardiac glycoside, digoxin, by human intestinal epithelial (Caco-2) cells. Br. J. Pharmacol. 118 (1996) 1389-1396
52. Feldmann T., Glukmann V., Friedman E., Shpolansky U., Galili D., Lichtstein D., and Rosen H. Role of endosomal Na+, K+-ATPase and cardiac steroids in the regulation of endocytosis. Am. J. Physiol. Cell Physiol. (2007)
53. Ruch S.R., Nishio M., and Wasserstrom J.A. Effect of cardiac glycosides on action potential characteristics and contractility in cat ventricular myocytes: role of calcium overload. J. Pharmacol. Exp. Ther. 307 (2003) 419-428
54. Kieval R.S., Butler Jr. V.P., Derguini F., Bruening R.C., and Rosen M.R. Cellular electrophysiologic effects of vertebrate digitalis-like substances. J. Am. Coll. Cardiol. 11 (1988) 637-643
55. Schlieper P., and Tawfik H. Antiarrhythmic activity of alpha-tocopherol nicotinate and related compounds and their physico-chemical properties. Arzneimittel-Forschung 37 (1987) 920-923
56. Pamnani M.B., Chen S., Bryant H.J., Schooley Jr. J.F., Eliades D.C., Yuan C.M., and Haddy F.J. Effects of three sodium-potassium adenosine triphosphatase inhibitors. Hypertension 18 (1991) 316-324
57. Segal J.B., McNamara R.L., Miller M.R., Kim N., Goodman S.N., Powe N.R., Robinson K., Yu D., and Bass E.B. The evidence regarding the drugs used for ventricular rate control. J. Fam. Pract. 49 (2000) 47-59
58. Fricke U., and Klaus W. The influence of reduced serum potassium level on the toxicity of some cardenolides in guinea pigs. Basic Res. Cardiol. 76 (1981) 62-78
59. Manunta P., Hamilton J., Rogowski A.C., Hamilton B.P., and Hamlyn J.M. Chronic hypertension induced by ouabain but not digoxin in the rat: antihypertensive effect of digoxin and digitoxin. Hypertens. Res. 23 (2000) S77-S85
60. Elkareh J., Kennedy D.J., Yashaswi B., Vetteth S., Shidyak A., Kim E.G., Smaili S., Periyasamy S.M., Hariri I.M., Fedorova L., Liu J., Wu L., Kahaleh M.B., Xie Z., Malhotra D., Fedorova O.V., Kashkin V.A., Bagrov A.Y., and Shapiro J.I. Marinobufagenin stimulates fibroblast collagen production and causes fibrosis in experimental uremic cardiomyopathy. Hypertension 49 (2007) 215-224
61. Huang B.S., Kudlac M., Kumarathasan R., and Leenen F.H. Digoxin prevents ouabain and high salt intake-induced hypertension in rats with sinoaortic denervation. Hypertension 34 (1999) 733-738
62. Kimura K., Manunta P., Hamilton B.P., and Hamlyn J.M. Different effects of in vivo ouabain and digoxin on renal artery function and blood pressure in the rat. Hypertens. Res. 23 (2000) S67-S76
63. Haddy F.J., and Pamnani M.B. Role of ouabain-like factors and Na-K-ATPase inhibitors in hypertension-some old and recent findings. Clin. Exp. Hypertens. 20 (1998) 499-508
64. Blaustein M.P., Zhang J., Chen L., and Hamilton B.P. How does salt retention raise blood pressure?. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290 (2006) R514-R523
65. Bagrov A.Y., Roukoyatkina N.I., Pinaev A.G., Dmitrieva R.I., and Fedorova O.V. Effects of two endogenous Na+, K(+)-ATPase inhibitors, marinobufagenin and ouabain, on isolated rat aorta. Eur. J. Pharmacol. 274 (1995) 151-158
66. Woolfson R.G., Graves J., LaBella F.S., Templeton J.F., and Poston L. Effect of bufalin and pregnanes on vasoreactivity of human resistance arteries. Biochem. Biophys. Res. Commun. 186 (1992) 1-7
67. Vu H.V., Ianosi-Irimie M.R., Pridjian C.A., Whitbred J.M., Durst J.M., Bagrov A.Y., Fedorova O.V., Pridjian G., and Puschett J.B. Involvement of marinobufagenin in a rat model of human preeclampsia. Am. J. Nephrol. 25 (2005) 520-528
68. Yates N.A., and McDougall J.G. Effects of direct renal arterial infusion of bufalin and ouabain in conscious sheep. Br. J. Pharmacol. 108 (1993) 627-630
69. Fedorova O.V., Agalakova N.I., Morrell C.H., Lakatta E.G., and Bagrov A.Y. ANP differentially modulates marinobufagenin-induced sodium pump inhibition in kidney and aorta. Hypertension 48 (2006) 1160-1168
70. Blaustein M.P. Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis. Am. J. Physiol. 232 (1977) C165-C173
71. Qiu L.Y., Krieger E., Schaftenaar G., Swarts H.G., Willems P.H., De Pont J.J., and Koenderink J.B. Reconstruction of the complete ouabain-binding pocket of Na, K-ATPase in gastric H, K-ATPase by substitution of only seven amino acids. J. Biol. Chem. 280 (2005) 32349-32355
72. Keenan S.M., DeLisle R.K., Welsh W.J., Paula S., and Ball Jr. W.J. Elucidation of the Na+, K+-ATPase digitalis binding site. J. Mol. Graph. Model. 23 (2005) 465-475
73. Crambert G., Hasler U., Beggah A.T., Yu C., Modyanov N.N., Horisberger J.D., Lelievre L., and Geering K. Transport and pharmacological properties of nine different human Na, K-ATPase isozymes. J. Biol. Chem. 275 (2000) 1976-1986
74. Muller-Ehmsen J., Juvvadi P., Thompson C.B., Tumyan L., Croyle M., Lingrel J.B., Schwinger R.H., McDonough A.A., and Farley R.A. Ouabain and substrate affinities of human Na(+)-K(+)-ATPase alpha(1)beta(1), alpha(2)beta(1), and alpha(3)beta(1) when expressed separately in yeast cells. Am. J. Physiol. Cell Physiol. 281 (2001) C1355-C1364
75. Wang J., Velotta J.B., McDonough A.A., and Farley R.A. All human Na(+)-K(+)-ATPase alpha-subunit isoforms have a similar affinity for cardiac glycosides. Am. J. Physiol. Cell Physiol. 281 (2001) C1336-C1343
76. Sweadner K.J. Enzymatic properties of separated isozymes of the Na, K-ATPase. Substrate affinities, kinetic cooperativity, and ion transport stoichiometry. J. Biol. Chem. 260 (1985) 11508-11513
77. Inoue N., Matsui H., Tsukui H., and Hatanaka H. The appearance of a highly digitalis-sensitive isoform of Na+, K+-ATPase during maturation in vitro of primary cultured rat cerebral neurons. J. Biochem. 104 (1988) 349-354
78. Akimova O.A., Lopina O.D., Hamet P., and Orlov S.N. Search for intermediates of Na+, K+-ATPase-mediated [Na+]i/[K+]i-independent death signaling triggered by cardiotonic steroids. Pathophysiology 12 (2005) 125-135
79. Gupta R.S., Chopra A., and Stetsko D.K. Cellular basis for the species differences in sensitivity to cardiac glycosides (digitalis). J. Cell. Physiol. 127 (1986) 197-206
80. Liang M., Tian J., Liu L., Pierre S., Liu J., Shapiro J., and Xie Z.J. Identification of a pool of non-pumping Na/K-ATPase. J. Biol. Chem. 282 (2007) 10585-10593